COMPASS Pathways plc Board of Directors

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Mr. Matthew Allen Owens

Mr. Matthew Allen Owens

General Counsel & Chief Legal Officer

Dr. Guy Goodwin

Dr. Guy Goodwin

Chief Medical Officer

Mr. Stephen D. Schultz

Mr. Stephen D. Schultz

Senior Vice President of Investor Relations

Mr. Christopher Williams

Mr. Christopher Williams

Chief Communications Officer

Ms. Anne Benedict

Ms. Anne Benedict

Chief People Officer

Dr. Greg Ryslik Ph.D.

Dr. Greg Ryslik Ph.D.

Chief Technology Officer

Ms. Teri Loxam M.B.A.

Ms. Teri Loxam M.B.A.

CFO, Principal Financial Officer & Principal Accounting Officer

Comments